Company Filing History:
Years Active: 2013-2021
Title: **The Innovative Contributions of Vicente Samano**
Introduction
Vicente Samano is a notable inventor based in Research Triangle Park, NC, with an impressive portfolio of nine patents. His work primarily focuses on the development of novel pharmaceutical compounds aimed at treating a variety of diseases. This article delves into his latest patents, career highlights, and collaborations that showcase his contributions to the field of biomedical innovation.
Latest Patents
Among Vicente Samano's most recent inventions are his patents related to modulators of indoleamine 2,3-dioxygenase (IDO). He has provided IDO inhibitor compounds of Formula I along with pharmaceutically acceptable salts, pharmaceutical compositions, methods of preparation, and strategies for their application in the prevention and treatment of diseases. Notably, these innovations target conditions such as chronic viral infections, chronic bacterial infections, cancer, sepsis, and various neurological disorders.
Career Highlights
Throughout his career, Vicente has made significant strides in the pharmaceutical industry by working with esteemed organizations such as GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline LLC. His contributions to these companies have been instrumental in advancing therapeutic options and enhancing patient care.
Collaborations
Vicente has collaborated with several distinguished professionals in the field, including Martha Alicia De La Rosa and Wieslaw Mieczyslaw Kazmierski. These partnerships have enriched his research efforts and facilitated the development of innovative solutions to complex health challenges.
Conclusion
Vicente Samano stands out as a prolific inventor whose work has had a tangible impact on the medical community. Through his innovative patents and collaborative spirit, he continues to drive advancements in the treatment of various diseases, demonstrating the essential role of inventors in the evolution of healthcare solutions.